Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors

Detalhes bibliográficos
Autor(a) principal: Tanaka, Aparecida Sadae [UNIFESP]
Data de Publicação: 1999
Outros Autores: Silva, Melissa M. [UNIFESP], Torquato, Ricardo Jose Soares [UNIFESP], Noguti, Maria Aparecida Eiko [UNIFESP], Sampaio, Claudio Augusto Machado [UNIFESP], Fritz, H., Auerswald, E. A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/S0014-5793(99)01106-0
http://repositorio.unifesp.br/handle/11600/26142
Resumo: The recombinant phage antibody system pCANTAB 5E has been used to display functionally active leech-derived tryptase inhibitor (LDTI) on the tip of the filamentous M13 phage, A limited combinatorial library of 5.2 x 10(4) mutants was created with a synthetic LDTI gene, using a degenerated oligonucleotide and the pCANTAB 5E phagemid. the mutations were restricted to the P1-P4' positions of the reactive site. Fusion phages and appropriate host strains containing the phagemids were selected after binding to thrombin and DNA sequencing. the variants LDTI-2T (K8R, I9V, S10, K11W, P12A), LDTI-5T (K8R, I9V, S10, K11S, P12L) and LDTI-10T (K8R, I9L, S10, K11D, P12I) were produced with a Saccharomyces cerevisiae expression system. the new inhibitors, LDTI-2T and -5T, prolong the blood clotting time, inhibit thrombin (Ki 302 nM and 28 nM) and trypsin (K-i 6.4 nM and 2.1 nM) but not factor Xa, plasma kallikrein or neutrophil elastase, the variant LDTI-10T binds to thrombin but does not inhibit it, the relevant reactive site sequences of the thrombin inhibiting variants showed a strong preference for arginine in position P1 (K8R) and for valine in P1' (I9V), the data indicate further that LDTI-5T might be a model candidate for generation of active-site directed thrombin inhibitors and that LDTI in general may be useful to generate specific inhibitors suitable for a better understanding of enzyme-inhibitor interactions. (C) 1999 Federation of European Biochemical Societies.
id UFSP_6155ac5f734086b3212b345a9eb49d3f
oai_identifier_str oai:repositorio.unifesp.br/:11600/26142
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitorsphage display systemthrombin inhibitorcombinatorial libraryKazal-type serine proteinase inhibitorfilamentous phageThe recombinant phage antibody system pCANTAB 5E has been used to display functionally active leech-derived tryptase inhibitor (LDTI) on the tip of the filamentous M13 phage, A limited combinatorial library of 5.2 x 10(4) mutants was created with a synthetic LDTI gene, using a degenerated oligonucleotide and the pCANTAB 5E phagemid. the mutations were restricted to the P1-P4' positions of the reactive site. Fusion phages and appropriate host strains containing the phagemids were selected after binding to thrombin and DNA sequencing. the variants LDTI-2T (K8R, I9V, S10, K11W, P12A), LDTI-5T (K8R, I9V, S10, K11S, P12L) and LDTI-10T (K8R, I9L, S10, K11D, P12I) were produced with a Saccharomyces cerevisiae expression system. the new inhibitors, LDTI-2T and -5T, prolong the blood clotting time, inhibit thrombin (Ki 302 nM and 28 nM) and trypsin (K-i 6.4 nM and 2.1 nM) but not factor Xa, plasma kallikrein or neutrophil elastase, the variant LDTI-10T binds to thrombin but does not inhibit it, the relevant reactive site sequences of the thrombin inhibiting variants showed a strong preference for arginine in position P1 (K8R) and for valine in P1' (I9V), the data indicate further that LDTI-5T might be a model candidate for generation of active-site directed thrombin inhibitors and that LDTI in general may be useful to generate specific inhibitors suitable for a better understanding of enzyme-inhibitor interactions. (C) 1999 Federation of European Biochemical Societies.UNIFESP, Dept Bioquim, EPM, BR-04044020 São Paulo, BrazilUniv Munich, Klinikum Innenstadt, Chirurg Klin & Poliklin, Klin Chem & Klin Biochem Abt, D-8000 Munich, GermanyUNIFESP, Dept Med, Disciplina Hematol, EPM, BR-04044020 São Paulo, BrazilUNIFESP, Dept Bioquim, EPM, BR-04044020 São Paulo, BrazilUNIFESP, Dept Med, Disciplina Hematol, EPM, BR-04044020 São Paulo, BrazilWeb of ScienceElsevier B.V.Universidade Federal de São Paulo (UNIFESP)Univ MunichTanaka, Aparecida Sadae [UNIFESP]Silva, Melissa M. [UNIFESP]Torquato, Ricardo Jose Soares [UNIFESP]Noguti, Maria Aparecida Eiko [UNIFESP]Sampaio, Claudio Augusto Machado [UNIFESP]Fritz, H.Auerswald, E. A.2016-01-24T12:30:53Z2016-01-24T12:30:53Z1999-09-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion11-16application/pdfhttp://dx.doi.org/10.1016/S0014-5793(99)01106-0Febs Letters. Amsterdam: Elsevier B.V., v. 458, n. 1, p. 11-16, 1999.10.1016/S0014-5793(99)01106-0WOS000082617200003.pdf0014-5793http://repositorio.unifesp.br/handle/11600/26142WOS:000082617200003engFebs Lettersinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-30T21:04:06Zoai:repositorio.unifesp.br/:11600/26142Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-30T21:04:06Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
title Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
spellingShingle Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
Tanaka, Aparecida Sadae [UNIFESP]
phage display system
thrombin inhibitor
combinatorial library
Kazal-type serine proteinase inhibitor
filamentous phage
title_short Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
title_full Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
title_fullStr Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
title_full_unstemmed Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
title_sort Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors
author Tanaka, Aparecida Sadae [UNIFESP]
author_facet Tanaka, Aparecida Sadae [UNIFESP]
Silva, Melissa M. [UNIFESP]
Torquato, Ricardo Jose Soares [UNIFESP]
Noguti, Maria Aparecida Eiko [UNIFESP]
Sampaio, Claudio Augusto Machado [UNIFESP]
Fritz, H.
Auerswald, E. A.
author_role author
author2 Silva, Melissa M. [UNIFESP]
Torquato, Ricardo Jose Soares [UNIFESP]
Noguti, Maria Aparecida Eiko [UNIFESP]
Sampaio, Claudio Augusto Machado [UNIFESP]
Fritz, H.
Auerswald, E. A.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Univ Munich
dc.contributor.author.fl_str_mv Tanaka, Aparecida Sadae [UNIFESP]
Silva, Melissa M. [UNIFESP]
Torquato, Ricardo Jose Soares [UNIFESP]
Noguti, Maria Aparecida Eiko [UNIFESP]
Sampaio, Claudio Augusto Machado [UNIFESP]
Fritz, H.
Auerswald, E. A.
dc.subject.por.fl_str_mv phage display system
thrombin inhibitor
combinatorial library
Kazal-type serine proteinase inhibitor
filamentous phage
topic phage display system
thrombin inhibitor
combinatorial library
Kazal-type serine proteinase inhibitor
filamentous phage
description The recombinant phage antibody system pCANTAB 5E has been used to display functionally active leech-derived tryptase inhibitor (LDTI) on the tip of the filamentous M13 phage, A limited combinatorial library of 5.2 x 10(4) mutants was created with a synthetic LDTI gene, using a degenerated oligonucleotide and the pCANTAB 5E phagemid. the mutations were restricted to the P1-P4' positions of the reactive site. Fusion phages and appropriate host strains containing the phagemids were selected after binding to thrombin and DNA sequencing. the variants LDTI-2T (K8R, I9V, S10, K11W, P12A), LDTI-5T (K8R, I9V, S10, K11S, P12L) and LDTI-10T (K8R, I9L, S10, K11D, P12I) were produced with a Saccharomyces cerevisiae expression system. the new inhibitors, LDTI-2T and -5T, prolong the blood clotting time, inhibit thrombin (Ki 302 nM and 28 nM) and trypsin (K-i 6.4 nM and 2.1 nM) but not factor Xa, plasma kallikrein or neutrophil elastase, the variant LDTI-10T binds to thrombin but does not inhibit it, the relevant reactive site sequences of the thrombin inhibiting variants showed a strong preference for arginine in position P1 (K8R) and for valine in P1' (I9V), the data indicate further that LDTI-5T might be a model candidate for generation of active-site directed thrombin inhibitors and that LDTI in general may be useful to generate specific inhibitors suitable for a better understanding of enzyme-inhibitor interactions. (C) 1999 Federation of European Biochemical Societies.
publishDate 1999
dc.date.none.fl_str_mv 1999-09-10
2016-01-24T12:30:53Z
2016-01-24T12:30:53Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/S0014-5793(99)01106-0
Febs Letters. Amsterdam: Elsevier B.V., v. 458, n. 1, p. 11-16, 1999.
10.1016/S0014-5793(99)01106-0
WOS000082617200003.pdf
0014-5793
http://repositorio.unifesp.br/handle/11600/26142
WOS:000082617200003
url http://dx.doi.org/10.1016/S0014-5793(99)01106-0
http://repositorio.unifesp.br/handle/11600/26142
identifier_str_mv Febs Letters. Amsterdam: Elsevier B.V., v. 458, n. 1, p. 11-16, 1999.
10.1016/S0014-5793(99)01106-0
WOS000082617200003.pdf
0014-5793
WOS:000082617200003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Febs Letters
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.format.none.fl_str_mv 11-16
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268343668965376